CFT8634 |
| Catalog No.GC65602 |
CFT8634는 특허 WO2021178920A1 화합물 174에서 추출한 BRD9를 표적으로 하는 분해제입니다. CFT8634는 활막 육종 및 SMARCB1이 결실된 고형 종양의 연구에 사용할 수 있습니다.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 2704617-96-7
Sample solution is provided at 25 µL, 10mM.
;)
,-1-7$$$37316672.jpg');)
;)
;)
$$$36806353.jpg');)
;33(7)%EF%BC%9A546-561$$$37156877.jpg');)
;)
;)
;)
%201124-1138.$$$35908550.jpg');)
%20766-780.$$$37100057.jpg');)
%20418-432.$$$36893736.jpg');)
%EF%BC%9A-240-255.$$$35108512.jpg');)
533-545$$$36543525.jpg');)
%201-13.$$$36600053.jpg');)
;)
CFT8634 is a degrader targeting BRD9 extracted from patent WO2021178920A1 compound 174. CFT8634 can be used for the research of synovial sarcoma and SMARCB1-deleted solid tumors[1].
[1]. Nasveschuk CG, et, al. Compounds for targeted degradation of brd9. WO2021178920A1.
Review for CFT8634
Average Rating: 5 (Based on Reviews and 30 reference(s) in Google Scholar.)
Review for CFT8634
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *